Indications
RotaTeq is indicated for the active immunisation of infants from the age of six weeks to 32 weeks for prevention of gastroenteritis due to rotavirus infection. RotaTeq is to be used on the basis of official recommendations.
Composition
- Active substance
- rotavirus serotype G1, rotavirus serotype G2, rotavirus serotype G3, rotavirus serotype G4, rotavirus serotype P1
- International name (INN)
- rotavirus vaccine, live
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- RotaTeq
- ATC code
- J07BH02
- Therapeutic area
- Immunization, Rotavirus Infections
- Marketing authorisation holder